Skip to main content

Table 4 CNVs in psychiatric screened controls

From: High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy

NIMH ID

Sex

Chr.

Start

size(bp)

 

Genes

Validation a

DGV

150-10762

F

2p21

44549759

8313

Loss

PREPL

Cus4

None

150-11782

F

3p26.3

2695544

355319

Loss

CNTN4

Cus3

6 overlap

150-10112

M

3q29

196860921

478408

Gain

DLG1, BDH1

Cat

6 overlap

150-13123

M

6q15

89803425

144012

Loss

SFRS13B, PM20D2, GABRR1

Cus4

None

150-12782

M

5p13.2

37534374

305290

Gain

WDR70, GDNF

Cus3

None

150-12491

M

7p22.1

5667980

255505

Gain

RNF216, ZNF815, OCM

Cat

2 overlap

150-11643

F

7q21.13

88200226

354752

Loss

ZNF804B, MGC26647

Cus4

8 overlap

150-10750a

F

8p21.3

22211184

167245

Gain

PIWIL2, SLC39A14, PPP3CC

Cus4

2 overlap

150-12293

M

8q12.1

56682642

214806

Gain

TMEM68, TGS1, LYN, RPS20

Cat

4 overlap

150-12964

M

9q21.32

86522765

193620

Gain

5 genes

Cus4

3 overlap

150-10354

M

9q31.1

105642367

226151

Loss

CYLC2

Cus4

1 overlap

150-10750a

F

9q34.3

140374217

229402

Gain

9 genes

Cus4

None

150-12487

M

12q12

40789970

3711960

Gain

13 genes

Cat

None

150-12111a

M

12q24.12

112181037

136012

Gain

ACAD10, ALDH2, C12orf47, MAPKAPK5

Cus4

None

150-10678

F

12q24.21

116367980

170923

Gain

MED13L

Cus4

1 overlap

150-10629

M

13q33.1

103192748

327792

Gain

7 genes

Cat

None

150-12138

M

15q11.2

22842143

244550

Gain

TUBGCP5, CYFIP1, NIPA2, NIPA1 b

MLPA

Common

150-11886

M

15q11.2

22842143

244550

Gain

TUBGCP5, CYFIP1, NIPA2, NIPA1 b

Cat

Common

150-12900

M

15q11.2

22842143

244550

Loss

TUBGCP5, CYFIP1, NIPA2, NIPA1

MLPA

Common

150-11785

F

15q13.3

31730445

694760

Gain

CHRNA7 c

Cat

Common

150-11943

M

15q15.1

42656727

32418

Loss

CAPN3

Cus4

None

150-12111a

M

16p13.3

2147596

18151

Gain

PKD1

Cus4

3 overlap

150-12420

M

17p13.2

4027661

492396

Gain

10 genesb

Cat

4 overlap

150-10080

M

17p13.1

9993838

416496

Gain

5 genes

Cat

None

150-12837

M

17p11.2

21195549

306380

Gain

MAP2K3, KCNJ12, C17orf51 b

Cat

13 overlap

150-12522

M

19q13.11

32809424

217110

Loss

ZNF507, DPY19L3

Cus4

None

150-10660

F

21q22

35720798

185606

Gain

KCNE2, FAM165B, KCNE1, RCAN1

Cus4

Identical

150-10685

M

22q11.21

18900180

2901481

Gain

50 genes

Cat

Common

150-10702

M

Xp22.12

19563240

384858

Gain

SH3KBP1, CXorf23

Cat

None

150-12093

M

Yp11.2

9523339

126272

Gain

8 genes

Cus4

None

  1. Abbreviations: As in Table 1.
  2. a denotes samples having more than one CNV
  3. b denotes controls which had a similar call to CNV found in cases